Conestoga Capital Advisors LLC Acquires 43,257 Shares of Exponent, Inc. (NASDAQ:EXPO)

Conestoga Capital Advisors LLC boosted its stake in Exponent, Inc. (NASDAQ:EXPOFree Report) by 1.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 2,806,517 shares of the business services provider’s stock after buying an additional 43,257 shares during the quarter. Exponent accounts for approximately 4.4% of Conestoga Capital Advisors LLC’s portfolio, making the stock its 2nd biggest position. Conestoga Capital Advisors LLC owned approximately 0.06% of Exponent worth $323,535,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of EXPO. Bamco Inc. NY purchased a new position in shares of Exponent in the first quarter worth $25,904,000. Vanguard Group Inc. increased its holdings in shares of Exponent by 5.8% in the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after acquiring an additional 291,047 shares during the period. Kayne Anderson Rudnick Investment Management LLC grew its stake in Exponent by 6.5% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after buying an additional 284,179 shares during the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Exponent in the 2nd quarter valued at about $22,050,000. Finally, International Assets Investment Management LLC purchased a new position in shares of Exponent in the 3rd quarter valued at about $11,261,000. Institutional investors own 92.37% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Truist Financial restated a “buy” rating and issued a $120.00 price target (up from $100.00) on shares of Exponent in a research report on Friday, July 26th.

View Our Latest Research Report on EXPO

Exponent Price Performance

Shares of EXPO stock traded up $0.19 during midday trading on Friday, reaching $94.57. 22,690 shares of the company traded hands, compared to its average volume of 245,806. The firm has a market cap of $4.80 billion, a PE ratio of 45.59 and a beta of 0.66. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75. The firm’s 50 day simple moving average is $108.56 and its two-hundred day simple moving average is $100.54.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be given a $0.28 dividend. This represents a $1.12 annualized dividend and a dividend yield of 1.18%. The ex-dividend date is Friday, December 6th. Exponent’s payout ratio is currently 54.11%.

Exponent Company Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.